Physician profile
Jae U Hong
NPI 1184611634
$16,295.66
in general payments reported to CMS, 2019-2025
46 companies · $1,855 in 2025
The $1,855 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,654 · 2020: $1,484 · 2021: $2,547 · 2022: $2,998 · 2023: $3,135 · 2024: $2,623 · 2025: $1,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,556 · Education: $57.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,555.92 |
| Education | $57.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,200.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,746.11 | 2019-2025 | |
| Lilly USA, LLC | $1,432.83 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,273.02 | 2019-2025 | Jardiance, Synjardy |
| Amgen INC. | $1,194.78 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,138.21 | 2019-2025 | Farxiga, Breztri, Bevespi Aerosphere |
| Pfizer INC. | $1,002.27 | 2019-2025 | |
| Glaxosmithkline, LLC. | $812.20 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $620.80 | 2021-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $491.93 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $419.25 | 2019-2023 | Xarelto |
| Allergan, INC. | $397.79 | 2019-2020 | |
| Exact Sciences Corporation | $352.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $310.26 | 2019-2023 | |
| Abbott Laboratories | $283.98 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.